SANOFI PASTEUR VAXDESIGN CORP has a total of 52 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are NEURALSTEM BIOPHARMACEUTICALS, SPHEROTEC GMBH and AUSTRALIAN STEM CELL CT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 20 | |
#2 | Australia | 8 | |
#3 | United States | 8 | |
#4 | Israel | 5 | |
#5 | Canada | 4 | |
#6 | Japan | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | China | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Chemical engineering | |
#5 | Agriculture | |
#6 | Audio-visual technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Chemical or physical laboratory devices | |
#5 | Microbiology | |
#6 | Peptides | |
#7 | Measuring microorganism processes | |
#8 | Animal care | |
#9 | Therapeutic chemical compounds | |
#10 | Television |
# | Name | Total Patents |
---|---|---|
#1 | Warren William L | 28 |
#2 | Fahlenkamp Heather | 16 |
#3 | Higbee Russell | 15 |
#4 | Mishkin Eric | 15 |
#5 | Parkhill Robert | 15 |
#6 | Sanchez-Schmitz Guzman | 13 |
#7 | Moser Janice | 12 |
#8 | Wittman Vaughan | 11 |
#9 | Singh Inderpal | 10 |
#10 | Kachurin Anatoly | 10 |
Publication | Filing date | Title |
---|---|---|
US2019187127A1 | In vitro neonatal biomimetic (nmimic) model and methods of using same | |
WO2016018940A1 | Automated imaging and analysis of the hemagglutination inhibition assay (hai) | |
EP2661623A2 | In vitro urogenital co-culture models | |
EP2491394A2 | Surface-assisted hemagglutination inhibition assays | |
CA2742804A1 | Fluorescent neutralization and adherence inhibition assays | |
EP2420516A1 | Rapid generation of T cell-independent antibody responses to T cell-dependent antigens | |
AU2008352548A1 | Disease model incorporation into an artificial immune system (AIS) | |
AU2007258279A1 | Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS) | |
AU2006330951A1 | A porous membrane device that promotes the differentiation of monocytes into dendritic cells | |
AU2006340324A1 | Automatable artificial immune system (AIS) | |
US2007015136A1 | Artificial lymphoid tissue equivalent |